Skip to main content
Trulieve Cannabis Corp. logo

Trulieve Cannabis Corp. — Investor Relations & Filings

Ticker · TRUL ISIN · CA89788C1041 LEI · 549300122MBOJDGEZ014 CSE Manufacturing
Filings indexed 902 across all filing types
Latest filing 2025-05-07 Interim / Quarterly Rep…
Country CA Canada
Listing CSE TRUL

About Trulieve Cannabis Corp.

https://www.trulieve.com/

Trulieve Cannabis Corp. is a leading vertically integrated multi-state operator (MSO) focused on the cultivation, processing, and retail distribution of branded cannabis products across the United States. The company manages the entire supply chain, distributing its offerings through a network of Trulieve branded dispensaries. Trulieve provides a comprehensive portfolio designed for consumer wellness, relaxation, and relief. Product categories include flower, edibles, vapes, concentrates, topicals, and accessories, marketed under various proprietary brands such as Avenue, Cultivar Collection, Muse, Modern Flower, Alchemy, and Momenta. The company's operational model emphasizes accessibility and control over product quality from seed to sale.

Recent filings

Filing Released Lang Actions
Other.pdf
Interim / Quarterly Report Classification · 100% confidence The document is a Form 10-Q, which is the standard quarterly report filed with the SEC by U.S. public companies. It contains unaudited condensed consolidated financial statements (balance sheets, statements of operations, cash flows, and changes in shareholders' equity) for the period ended March 31, 2025. This fits the definition of an Interim / Quarterly Report (IR). Q1 2025
2025-05-07 English
52-109F2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings Classification · 100% confidence The document consists entirely of Sarbanes-Oxley Act Section 302 and Section 906 certifications signed by the CEO and CFO. It references a Quarterly Report on Form 10-Q but does not contain the actual financial statements or substantive financial data of the report itself. According to the 'CERTIFICATION RULE', documents that are primarily officer certifications or attestations should be classified as Regulatory Filings (RNS). Q1 2025
2025-05-07 English
52-109F2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings Classification · 100% confidence The document consists entirely of Sarbanes-Oxley Act Section 302 and Section 906 certifications signed by company officers. It references a Quarterly Report on Form 10-Q but does not contain the actual financial statements or substantive financial data of the report itself. According to the 'CERTIFICATION RULE', documents that are primarily officer certifications or attestations should be classified as Regulatory Filings (RNS). Q1 2025
2025-05-07 English
Interim MD&A - English.pdf
Interim / Quarterly Report Classification · 100% confidence The document is an excerpt from a 'Quarterly Report on Form 10-Q' for Trulieve Cannabis Corp. It explicitly references 'Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations' and discusses the company's operational structure, market position, and business strategy for the period ending March 31, 2025. While it contains management's discussion, it is part of a formal 10-Q filing, which falls under the category of an Interim/Quarterly Report. FY 2024
2025-05-07 English
Interim financial statements/report – English.pdf
Interim / Quarterly Report Classification · 100% confidence The document contains comprehensive unaudited condensed consolidated financial statements, including balance sheets, statements of operations, statements of changes in shareholders' equity, and statements of cash flows for the quarter ended March 31, 2025. It explicitly references being part of a Form 10-Q filing. As it provides substantive financial data and analysis for an interim period, it is classified as an Interim/Quarterly Report. Q1 2025
2025-05-07 English
Other.pdf
Investor Presentation Classification · 93% confidence The document is titled “First Quarter 2025 Investor Presentation” and contains typical slide structure (agenda, forward-looking statements, non-GAAP reconciliations, financial and operational highlights, charts, images, and forward-looking metrics). It is clearly a detailed investor deck rather than a regulatory filing, earnings press release, or full annual/interim report. Therefore it fits the “Investor Presentation” category.
2025-05-07 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.